Member Info for ShearClass

Yep, that is incorrect - very bad behaviour from an upstart competitor. The below from the 31st Jan RNS (How long ago does that seem?!)

"The Primerdesign test is also stable at ambient temperatures, which eliminates the need for cold chain shipping in tropical climates and therefore improves the efficiency of the test and reduces transport costs."

Sorry should say French rules...

Negma are long gone, absolute non starter as far as I’m concerned.

It’s a shame there isn’t more transparency, but that’s life!

@Blue, the answer is at the bottom of every total voting rights / loan conversion RNS :

“The total number of ordinary shares in the Company is 67,673,567. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company pursuant to Article L. 223-7 of the French Commercial Code and the Company's Articles.

The Company is not subject to the disclosure guidance and transparency rules made by the Financial Conduct Authority under Part VI of FSMA.”

They didn’t have to report their holding changes as they report under French types, not FCA.

I discovered this way back on the morning of 30th Jan when I first bought shares here

Greater than 50% EBITDA margin - and given we don’t have any debt now, and minimal depreciation, that will translate into 50% + Profit before tax...

This is the RENX board, post that on NCYT if you want an answer - however it's pretty obvious if you do your research ;)

Tremendous news again today - a brilliant week for RENX. Look forward to this listing on the NASDAQ where investors actually appreciate quality companies. For now it’s AIM with 6 trades in the first hour on the confirmation of revenue generation in Q3 in a US market where an estimated 12 million could benefit from the test...

@Jonnykipper, the market wants you to give up and chase something that’s rising - that’s human psychology and one of the main reasons so many lose money...

NCYT are in a fantastic position, the share price is simply rebasing itself and will appreciate in value as time passes / news arrives. Cash generation of around £20m per month will add nearly 30p per share in June alone... same for July, August, September etc.

Playing the percentages really, the odds are stacked well in our favour from the current level.

The imminent new product releases appear to be perfectly timed for the second wave, they will attract new money and the price will recover back to 350+ IMO

Always nice to be recommended in a list of 3 companies...

https://www.standard.co.uk/business/stock-market-ftse-aim-coronavirus-a4465291.html

Tasty late £200k buy reported from this morning - spread was 240-250 when it went through at 250, so it's 100% a buy :)

I like the tanker analogy - certainly the exchange of shares today between new buyers & exiting holders (looks like another II selling down) is representative of the change. Big sells this morning & late afternoon were all that stopped this rising well beyond 8p. In total 13.6m traded, need a lot more days like this but with word spreading & the political climate very much in our favour I don't see volume being a problem. More RNS's like Monday's will also help!

Also reported, at best a very thick interpretation and at worst an attempt to spread panic - the stupidest thing is NCYT haven't raised any money! If you want unfair behaviour have a look at the three raises done by AVCT since the start of April, utterly shocking for PI's.

This has RNS tomorrow AM written all over it - rise this morning when someone somewhere got a whiff of something, then dragged back down by the market makers to gather shares. Particularly the last 15 minutes... Would also make a lot of sense to have an update on progress pre presentation anyway...

Yep, listening to him talk about the Cytiva test the excuses seemed to be being lined up - especially - 'these processes normally take at least a year, but we're trying to reduce that, however that increases the risk of things going wrong'....

Volume quite impressive so far today, certainly getting onto the radar of a lot more PI's and the word is spreading...

"It’s not just that they’re looking to participate in these markets either, what Avacta have exclusive control over is a technology that could revolutionise them"

They absolutely do not have exclusive control over Affimers - they state that they are difficult to reverse engineer, but that interesting paper posted by PL75 on here last week re. creating an Affimer based test for a different virus shows that others can create them. It would be like saying a company had exclusive control over antibodies etc.

When's the half year update usually released Truro? If further positive news is released regarding renewables then these levels will be a thing of the past...

Yep, I noticed that https://kantarobio.com/ was updated over the weekend, they changed “tests will be available soon”, to “planned for July 2020”, so all appears on track...

Forensic, you are very high and mighty in your comparison between MANO & LIT. Their respective profit before tax figures are likely to be similar for the year, and fundamentally they both operate in the legal services sector (unlike your silly comparison of Tesco and BP...) so why is MANO valued 288% higher than LIT?

You also omit that Burford were also valued at 4 x their current share price this time last year, so prior to their current problems the market certainly valued them very highly indeed, suggesting that negative sentiment rather than business models is the reason for the current valuation discrepancy.

Yep, and having both the cash resources and 400 skilled employees to utilise will certainly help accelerate progress...

From 16th April RNS:

"The Programme was initiated in late 2019 and has been accelerated to meet emerging needs. It is currently funded from TP Group's existing resources and will last a further three months. In that time, proven technologies developed under a range of submarine life support programmes will be combined to generate low-carbon supplies of hydrogen or oxygen according to end-user requirements. The first phase of the project aims to produce a demonstration system at the Group's Portsmouth facility that can be tested for suitability and performance. From there, it is anticipated that future modular units to suit a range of needs can be specified in consultation with customers and partners for development activities to commence in the second half of 2020."

The potential of the future modular units to suit a range of needs is where the excitement lies, and given the project was scheduled to run for 3 months commencing 16th April, further details should emerge in the next 6 weeks....